Kevin Mouillesseaux, PhD, joined StrideBio in October 2016, when the entire company could take conference calls around a single Bluetooth speakerphone. Dr Mouillesseaux leads StrideBio’s upstream and downstream process development efforts and engineered the company’s proprietary suspension producer cell line, HEKMo. Before coming to StrideBio, Dr Mouillesseaux worked in Biogen’s small-scale upstream process development group. As an academic scientist, Dr Mouillesseaux earned his doctorate at the University of California, Los Angeles, using molecular and cellular biology and genetics to study endothelial cell biology in the zebrafish model organism. During his postdoctoral fellowship at the University of North Carolina at Chapel Hill, Dr Mouillesseaux leveraged those same skills to study intercellular communication during cell fate determination.
